Stephens Investment Management Group LLC / HALO
Stephens Investment Management Group LLC’s Halozyme Therapeutics Inc Position
Does Stephens Investment Management Group LLC own Halozyme Therapeutics Inc (HALO)? Yes — 1.22M shares worth $79M (+1.08% of its 13F portfolio) as of Q1 2026, down from 1.22M shares the prior filed quarter.
Position Value
$79M
Q1 2026
Shares
1.22M
% of Portfolio
+1.08%
Quarters Held
24
currently held
Position History HALO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.22M | $79M | +1.08% |
| Q4 2025 | 1.22M | $82M | +1.07% |
| Q3 2025 | 1.23M | $90M | +1.16% |
| Q2 2025 | 1.29M | $67M | +0.89% |
| Q1 2025 | 1.34M | $85M | +1.23% |
| Q4 2024 | 1.35M | $64M | +0.86% |
| Q3 2024 | 1.36M | $78M | +1.06% |
| Q2 2024 | 1.42M | $74M | +1.04% |
| Q1 2024 | 1.55M | $63M | +0.84% |
| Q4 2023 | 1.52M | $56M | +0.82% |
| Q3 2023 | 1.45M | $56M | +0.91% |
| Q2 2023 | 1.34M | $48M | +0.75% |
| Q1 2023 | 1.31M | $50M | +0.84% |
| Q4 2022 | 1.29M | $74M | +1.34% |
| Q3 2022 | 1.30M | $51M | +0.97% |
| Q2 2022 | 1.30M | $57M | +1.06% |
| Q1 2022 | 1.29M | $52M | +0.76% |
| Q4 2021 | 1.27M | $51M | +0.66% |
| Q3 2021 | 1.27M | $52M | +0.70% |
| Q2 2021 | 1.10M | $50M | +0.68% |
| Q1 2021 | 1.09M | $46M | +0.66% |
| Q4 2020 | 974.2K | $42M | +0.62% |
| Q3 2020 | 268.9K | $7M | +0.12% |
| Q2 2020 | 174.3K | $5M | +0.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stephens Investment Management Group LLC’s full portfolio or all institutional holders of HALO.